Healthcare DIVE August 2, 2024
Emily Olsen

The deal with private equity firms TowerBrook and CD&R comes months after New Mountain Capital announced its own takeover bid, which some analysts thought undervalued the company.

Dive Brief:

  • Private equity firms TowerBrook Capital Partners and Clayton, Dubilier and Rice entered into a definitive agreement to acquire R1 RCM for about $8.9 billion and take the company private, the revenue cycle management firm said Thursday.
  • TowerBrook currently controls around 36% of the company’s shares, according to a press release. Under the deal, which will take R1 private, TowerBrook and CD&R will buy the rest of the company’s outstanding stock for $14.30 per share.
  • The acquisition comes months after another private equity firm, New Mountain Capital, offered to buy...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Mergers & Acquisitions / JV, RCM (Revenue Cycle Mgmt), Technology, Trends
Unlocking Hidden Revenue: Transforming RCM Challenges into Financial Wins
Protecting revenue integrity in the age of denials — 4 takeaways
8 Tips for Effective Revenue Cycle Technology Management
Aspirion names CEO
R1 RCM posts $19.9M net loss in Q3

Share This Article